Related Experiment Videos
Reticulosarcoma occurring during long-term hemodialysis.
Clinical Nephrology
|January 1, 1975
Summary
Long-term hemodialysis for kidney failure may increase cancer risk. Uremia-induced immunosuppression might contribute to reticulosarcoma development and de-novo malignancies in transplant patients.
Area of Science:
- Nephrology
- Oncology
- Immunology
Background:
- Chronic renal failure (CRF) management often involves long-term hemodialysis.
- Polycystic kidney disease (PKD) is a common cause of end-stage renal disease requiring renal replacement therapy.
- Uremia, a state of kidney dysfunction, is associated with altered immune function.
Observation:
- A case of reticulosarcoma with cerebral involvement is presented in a patient undergoing maintenance hemodialysis for PKD.
- The patient developed cancer during the course of long-term hemodialysis treatment.
Findings:
- Reticulosarcoma, a type of non-Hodgkin lymphoma, occurred in the context of chronic hemodialysis.
- Cerebral involvement suggests advanced disease progression.
Implications:
- Uremia-induced immunosuppression may play a role in cancer development during hemodialysis.
- This case highlights a potential link between immunosuppression in chronic kidney disease patients and increased malignancy risk.
- Findings suggest a need for vigilance regarding de-novo malignancies in patients with end-stage renal disease and those who have received kidney transplants.